1 Study Coverage
    1.1 Interventional Lung Disease Product Introduction
    1.2 Market by Type
        1.2.1 Global Interventional Lung Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bronchoscopes
        1.2.3 Respiratory Endotherapy Devices
        1.2.4 ENB Systems
        1.2.5 Pleuroscopes
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Interventional Lung Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Emergency Center
        1.3.4 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Interventional Lung Disease Sales Estimates and Forecasts 2017-2028
    2.2 Global Interventional Lung Disease Revenue Estimates and Forecasts 2017-2028
    2.3 Global Interventional Lung Disease Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Interventional Lung Disease Sales by Region
        2.4.1 Global Interventional Lung Disease Sales by Region (2017-2022)
        2.4.2 Global Sales Interventional Lung Disease by Region (2023-2028)
    2.5 Global Interventional Lung Disease Revenue by Region
        2.5.1 Global Interventional Lung Disease Revenue by Region (2017-2022)
        2.5.2 Global Interventional Lung Disease Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Interventional Lung Disease Sales by Manufacturers
        3.1.1 Global Top Interventional Lung Disease Manufacturers by Sales (2017-2022)
        3.1.2 Global Interventional Lung Disease Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interventional Lung Disease in 2021
    3.2 Global Interventional Lung Disease Revenue by Manufacturers
        3.2.1 Global Interventional Lung Disease Revenue by Manufacturers (2017-2022)
        3.2.2 Global Interventional Lung Disease Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Interventional Lung Disease Revenue in 2021
    3.3 Global Interventional Lung Disease Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Interventional Lung Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Interventional Lung Disease Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Interventional Lung Disease Sales by Type
        4.1.1 Global Interventional Lung Disease Historical Sales by Type (2017-2022)
        4.1.2 Global Interventional Lung Disease Forecasted Sales by Type (2023-2028)
        4.1.3 Global Interventional Lung Disease Sales Market Share by Type (2017-2028)
    4.2 Global Interventional Lung Disease Revenue by Type
        4.2.1 Global Interventional Lung Disease Historical Revenue by Type (2017-2022)
        4.2.2 Global Interventional Lung Disease Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    4.3 Global Interventional Lung Disease Price by Type
        4.3.1 Global Interventional Lung Disease Price by Type (2017-2022)
        4.3.2 Global Interventional Lung Disease Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Interventional Lung Disease Sales by Application
        5.1.1 Global Interventional Lung Disease Historical Sales by Application (2017-2022)
        5.1.2 Global Interventional Lung Disease Forecasted Sales by Application (2023-2028)
        5.1.3 Global Interventional Lung Disease Sales Market Share by Application (2017-2028)
    5.2 Global Interventional Lung Disease Revenue by Application
        5.2.1 Global Interventional Lung Disease Historical Revenue by Application (2017-2022)
        5.2.2 Global Interventional Lung Disease Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    5.3 Global Interventional Lung Disease Price by Application
        5.3.1 Global Interventional Lung Disease Price by Application (2017-2022)
        5.3.2 Global Interventional Lung Disease Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Interventional Lung Disease Market Size by Type
        6.1.1 North America Interventional Lung Disease Sales by Type (2017-2028)
        6.1.2 North America Interventional Lung Disease Revenue by Type (2017-2028)
    6.2 North America Interventional Lung Disease Market Size by Application
        6.2.1 North America Interventional Lung Disease Sales by Application (2017-2028)
        6.2.2 North America Interventional Lung Disease Revenue by Application (2017-2028)
    6.3 North America Interventional Lung Disease Market Size by Country
        6.3.1 North America Interventional Lung Disease Sales by Country (2017-2028)
        6.3.2 North America Interventional Lung Disease Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Interventional Lung Disease Market Size by Type
        7.1.1 Europe Interventional Lung Disease Sales by Type (2017-2028)
        7.1.2 Europe Interventional Lung Disease Revenue by Type (2017-2028)
    7.2 Europe Interventional Lung Disease Market Size by Application
        7.2.1 Europe Interventional Lung Disease Sales by Application (2017-2028)
        7.2.2 Europe Interventional Lung Disease Revenue by Application (2017-2028)
    7.3 Europe Interventional Lung Disease Market Size by Country
        7.3.1 Europe Interventional Lung Disease Sales by Country (2017-2028)
        7.3.2 Europe Interventional Lung Disease Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Interventional Lung Disease Market Size by Type
        8.1.1 Asia Pacific Interventional Lung Disease Sales by Type (2017-2028)
        8.1.2 Asia Pacific Interventional Lung Disease Revenue by Type (2017-2028)
    8.2 Asia Pacific Interventional Lung Disease Market Size by Application
        8.2.1 Asia Pacific Interventional Lung Disease Sales by Application (2017-2028)
        8.2.2 Asia Pacific Interventional Lung Disease Revenue by Application (2017-2028)
    8.3 Asia Pacific Interventional Lung Disease Market Size by Region
        8.3.1 Asia Pacific Interventional Lung Disease Sales by Region (2017-2028)
        8.3.2 Asia Pacific Interventional Lung Disease Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Interventional Lung Disease Market Size by Type
        9.1.1 Latin America Interventional Lung Disease Sales by Type (2017-2028)
        9.1.2 Latin America Interventional Lung Disease Revenue by Type (2017-2028)
    9.2 Latin America Interventional Lung Disease Market Size by Application
        9.2.1 Latin America Interventional Lung Disease Sales by Application (2017-2028)
        9.2.2 Latin America Interventional Lung Disease Revenue by Application (2017-2028)
    9.3 Latin America Interventional Lung Disease Market Size by Country
        9.3.1 Latin America Interventional Lung Disease Sales by Country (2017-2028)
        9.3.2 Latin America Interventional Lung Disease Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Interventional Lung Disease Market Size by Type
        10.1.1 Middle East and Africa Interventional Lung Disease Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Interventional Lung Disease Revenue by Type (2017-2028)
    10.2 Middle East and Africa Interventional Lung Disease Market Size by Application
        10.2.1 Middle East and Africa Interventional Lung Disease Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Interventional Lung Disease Revenue by Application (2017-2028)
    10.3 Middle East and Africa Interventional Lung Disease Market Size by Country
        10.3.1 Middle East and Africa Interventional Lung Disease Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Interventional Lung Disease Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Boston Scientific
        11.1.1 Boston Scientific Corporation Information
        11.1.2 Boston Scientific Overview
        11.1.3 Boston Scientific Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Boston Scientific Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boston Scientific Recent Developments
    11.2 Olympus
        11.2.1 Olympus Corporation Information
        11.2.2 Olympus Overview
        11.2.3 Olympus Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Olympus Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Olympus Recent Developments
    11.3 FUJIFILM
        11.3.1 FUJIFILM Corporation Information
        11.3.2 FUJIFILM Overview
        11.3.3 FUJIFILM Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 FUJIFILM Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 FUJIFILM Recent Developments
    11.4 Becton, Dickinson and Company
        11.4.1 Becton, Dickinson and Company Corporation Information
        11.4.2 Becton, Dickinson and Company Overview
        11.4.3 Becton, Dickinson and Company Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Becton, Dickinson and Company Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Becton, Dickinson and Company Recent Developments
    11.5 Smiths Group
        11.5.1 Smiths Group Corporation Information
        11.5.2 Smiths Group Overview
        11.5.3 Smiths Group Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Smiths Group Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Smiths Group Recent Developments
    11.6 Cook Medical
        11.6.1 Cook Medical Corporation Information
        11.6.2 Cook Medical Overview
        11.6.3 Cook Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Cook Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Cook Medical Recent Developments
    11.7 Vygon
        11.7.1 Vygon Corporation Information
        11.7.2 Vygon Overview
        11.7.3 Vygon Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Vygon Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Vygon Recent Developments
    11.8 PENTAX Medical
        11.8.1 PENTAX Medical Corporation Information
        11.8.2 PENTAX Medical Overview
        11.8.3 PENTAX Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 PENTAX Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 PENTAX Medical Recent Developments
    11.9 Clarus Medical
        11.9.1 Clarus Medical Corporation Information
        11.9.2 Clarus Medical Overview
        11.9.3 Clarus Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Clarus Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Clarus Medical Recent Developments
    11.10 HUGER Medical Instrument
        11.10.1 HUGER Medical Instrument Corporation Information
        11.10.2 HUGER Medical Instrument Overview
        11.10.3 HUGER Medical Instrument Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 HUGER Medical Instrument Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 HUGER Medical Instrument Recent Developments
    11.11 Richard Wolf
        11.11.1 Richard Wolf Corporation Information
        11.11.2 Richard Wolf Overview
        11.11.3 Richard Wolf Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Richard Wolf Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Richard Wolf Recent Developments
    11.12 Karl Storz
        11.12.1 Karl Storz Corporation Information
        11.12.2 Karl Storz Overview
        11.12.3 Karl Storz Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Karl Storz Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Karl Storz Recent Developments
    11.13 Taewoong Medical
        11.13.1 Taewoong Medical Corporation Information
        11.13.2 Taewoong Medical Overview
        11.13.3 Taewoong Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Taewoong Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Taewoong Medical Recent Developments
    11.14 ELLA - CS
        11.14.1 ELLA - CS Corporation Information
        11.14.2 ELLA - CS Overview
        11.14.3 ELLA - CS Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 ELLA - CS Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 ELLA - CS Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Interventional Lung Disease Industry Chain Analysis
    12.2 Interventional Lung Disease Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Interventional Lung Disease Production Mode & Process
    12.4 Interventional Lung Disease Sales and Marketing
        12.4.1 Interventional Lung Disease Sales Channels
        12.4.2 Interventional Lung Disease Distributors
    12.5 Interventional Lung Disease Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Interventional Lung Disease Industry Trends
    13.2 Interventional Lung Disease Market Drivers
    13.3 Interventional Lung Disease Market Challenges
    13.4 Interventional Lung Disease Market Restraints
14 Key Findings in The Global Interventional Lung Disease Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Interventional Lung Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Bronchoscopes
    Table 3. Major Manufacturers of Respiratory Endotherapy Devices
    Table 4. Major Manufacturers of ENB Systems
    Table 5. Major Manufacturers of Pleuroscopes
    Table 6. Major Manufacturers of Other
    Table 7. Global Interventional Lung Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Interventional Lung Disease Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Interventional Lung Disease Sales by Region (2017-2022) & (K Units)
    Table 10. Global Interventional Lung Disease Sales Market Share by Region (2017-2022)
    Table 11. Global Interventional Lung Disease Sales by Region (2023-2028) & (K Units)
    Table 12. Global Interventional Lung Disease Sales Market Share by Region (2023-2028)
    Table 13. Global Interventional Lung Disease Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Interventional Lung Disease Revenue Market Share by Region (2017-2022)
    Table 15. Global Interventional Lung Disease Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Interventional Lung Disease Revenue Market Share by Region (2023-2028)
    Table 17. Global Interventional Lung Disease Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Interventional Lung Disease Sales Share by Manufacturers (2017-2022)
    Table 19. Global Interventional Lung Disease Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Interventional Lung Disease Revenue Share by Manufacturers (2017-2022)
    Table 21. Interventional Lung Disease Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Interventional Lung Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Interventional Lung Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Lung Disease as of 2021)
    Table 24. Interventional Lung Disease Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Interventional Lung Disease Product Offered
    Table 26. Date of Manufacturers Enter into Interventional Lung Disease Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Interventional Lung Disease Sales by Type (2017-2022) & (K Units)
    Table 29. Global Interventional Lung Disease Sales by Type (2023-2028) & (K Units)
    Table 30. Global Interventional Lung Disease Sales Share by Type (2017-2022)
    Table 31. Global Interventional Lung Disease Sales Share by Type (2023-2028)
    Table 32. Global Interventional Lung Disease Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Interventional Lung Disease Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Interventional Lung Disease Revenue Share by Type (2017-2022)
    Table 35. Global Interventional Lung Disease Revenue Share by Type (2023-2028)
    Table 36. Interventional Lung Disease Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Interventional Lung Disease Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Interventional Lung Disease Sales by Application (2017-2022) & (K Units)
    Table 39. Global Interventional Lung Disease Sales by Application (2023-2028) & (K Units)
    Table 40. Global Interventional Lung Disease Sales Share by Application (2017-2022)
    Table 41. Global Interventional Lung Disease Sales Share by Application (2023-2028)
    Table 42. Global Interventional Lung Disease Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Interventional Lung Disease Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Interventional Lung Disease Revenue Share by Application (2017-2022)
    Table 45. Global Interventional Lung Disease Revenue Share by Application (2023-2028)
    Table 46. Interventional Lung Disease Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Interventional Lung Disease Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Interventional Lung Disease Sales by Type (2017-2022) & (K Units)
    Table 49. North America Interventional Lung Disease Sales by Type (2023-2028) & (K Units)
    Table 50. North America Interventional Lung Disease Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Interventional Lung Disease Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Interventional Lung Disease Sales by Application (2017-2022) & (K Units)
    Table 53. North America Interventional Lung Disease Sales by Application (2023-2028) & (K Units)
    Table 54. North America Interventional Lung Disease Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Interventional Lung Disease Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Interventional Lung Disease Sales by Country (2017-2022) & (K Units)
    Table 57. North America Interventional Lung Disease Sales by Country (2023-2028) & (K Units)
    Table 58. North America Interventional Lung Disease Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Interventional Lung Disease Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Interventional Lung Disease Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Interventional Lung Disease Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Interventional Lung Disease Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Interventional Lung Disease Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Interventional Lung Disease Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Interventional Lung Disease Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Interventional Lung Disease Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Interventional Lung Disease Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Interventional Lung Disease Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Interventional Lung Disease Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Interventional Lung Disease Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Interventional Lung Disease Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Interventional Lung Disease Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Interventional Lung Disease Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Interventional Lung Disease Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Interventional Lung Disease Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Interventional Lung Disease Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Interventional Lung Disease Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Interventional Lung Disease Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Interventional Lung Disease Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Interventional Lung Disease Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Interventional Lung Disease Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Interventional Lung Disease Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Interventional Lung Disease Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Interventional Lung Disease Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Interventional Lung Disease Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Interventional Lung Disease Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Interventional Lung Disease Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Interventional Lung Disease Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Interventional Lung Disease Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Interventional Lung Disease Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Interventional Lung Disease Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Interventional Lung Disease Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Interventional Lung Disease Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Interventional Lung Disease Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Interventional Lung Disease Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Interventional Lung Disease Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Interventional Lung Disease Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Interventional Lung Disease Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Interventional Lung Disease Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Interventional Lung Disease Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Interventional Lung Disease Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Interventional Lung Disease Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Interventional Lung Disease Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Interventional Lung Disease Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Interventional Lung Disease Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Interventional Lung Disease Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Interventional Lung Disease Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Boston Scientific Corporation Information
    Table 109. Boston Scientific Description and Major Businesses
    Table 110. Boston Scientific Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Boston Scientific Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Boston Scientific Recent Developments
    Table 113. Olympus Corporation Information
    Table 114. Olympus Description and Major Businesses
    Table 115. Olympus Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Olympus Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Olympus Recent Developments
    Table 118. FUJIFILM Corporation Information
    Table 119. FUJIFILM Description and Major Businesses
    Table 120. FUJIFILM Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. FUJIFILM Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. FUJIFILM Recent Developments
    Table 123. Becton, Dickinson and Company Corporation Information
    Table 124. Becton, Dickinson and Company Description and Major Businesses
    Table 125. Becton, Dickinson and Company Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Becton, Dickinson and Company Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Becton, Dickinson and Company Recent Developments
    Table 128. Smiths Group Corporation Information
    Table 129. Smiths Group Description and Major Businesses
    Table 130. Smiths Group Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Smiths Group Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Smiths Group Recent Developments
    Table 133. Cook Medical Corporation Information
    Table 134. Cook Medical Description and Major Businesses
    Table 135. Cook Medical Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Cook Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Cook Medical Recent Developments
    Table 138. Vygon Corporation Information
    Table 139. Vygon Description and Major Businesses
    Table 140. Vygon Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Vygon Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Vygon Recent Developments
    Table 143. PENTAX Medical Corporation Information
    Table 144. PENTAX Medical Description and Major Businesses
    Table 145. PENTAX Medical Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. PENTAX Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. PENTAX Medical Recent Developments
    Table 148. Clarus Medical Corporation Information
    Table 149. Clarus Medical Description and Major Businesses
    Table 150. Clarus Medical Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Clarus Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Clarus Medical Recent Developments
    Table 153. HUGER Medical Instrument Corporation Information
    Table 154. HUGER Medical Instrument Description and Major Businesses
    Table 155. HUGER Medical Instrument Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. HUGER Medical Instrument Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. HUGER Medical Instrument Recent Developments
    Table 158. Richard Wolf Corporation Information
    Table 159. Richard Wolf Description and Major Businesses
    Table 160. Richard Wolf Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Richard Wolf Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Richard Wolf Recent Developments
    Table 163. Karl Storz Corporation Information
    Table 164. Karl Storz Description and Major Businesses
    Table 165. Karl Storz Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. Karl Storz Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Karl Storz Recent Developments
    Table 168. Taewoong Medical Corporation Information
    Table 169. Taewoong Medical Description and Major Businesses
    Table 170. Taewoong Medical Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. Taewoong Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Taewoong Medical Recent Developments
    Table 173. ELLA - CS Corporation Information
    Table 174. ELLA - CS Description and Major Businesses
    Table 175. ELLA - CS Interventional Lung Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 176. ELLA - CS Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. ELLA - CS Recent Developments
    Table 178. Key Raw Materials Lists
    Table 179. Raw Materials Key Suppliers Lists
    Table 180. Interventional Lung Disease Distributors List
    Table 181. Interventional Lung Disease Customers List
    Table 182. Interventional Lung Disease Market Trends
    Table 183. Interventional Lung Disease Market Drivers
    Table 184. Interventional Lung Disease Market Challenges
    Table 185. Interventional Lung Disease Market Restraints
    Table 186. Research Programs/Design for This Report
    Table 187. Key Data Information from Secondary Sources
    Table 188. Key Data Information from Primary Sources
List of Figures
    Figure 1. Interventional Lung Disease Product Picture
    Figure 3. Global Interventional Lung Disease Market Share by Type in 2021 & 2028
    Figure 3. Bronchoscopes Product Picture
    Figure 4. Respiratory Endotherapy Devices Product Picture
    Figure 5. ENB Systems Product Picture
    Figure 6. Pleuroscopes Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Interventional Lung Disease Market Share by Application in 2021 & 2028
    Figure 9. Hospital
    Figure 10. Emergency Center
    Figure 11. Clinic
    Figure 12. Interventional Lung Disease Report Years Considered
    Figure 13. Global Interventional Lung Disease Sales 2017-2028 (K Units)
    Figure 14. Global Interventional Lung Disease Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Interventional Lung Disease Revenue 2017-2028 (US$ Million)
    Figure 16. Global Interventional Lung Disease Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Interventional Lung Disease Sales Market Share by Region (2017-2022)
    Figure 18. Global Interventional Lung Disease Sales Market Share by Region (2023-2028)
    Figure 19. North America Interventional Lung Disease Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Interventional Lung Disease Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Interventional Lung Disease Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Interventional Lung Disease Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Interventional Lung Disease Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Interventional Lung Disease Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Interventional Lung Disease Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Interventional Lung Disease Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Interventional Lung Disease Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Interventional Lung Disease Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Interventional Lung Disease Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Interventional Lung Disease in the World: Market Share by Interventional Lung Disease Revenue in 2021
    Figure 31. Global Interventional Lung Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Interventional Lung Disease Sales Market Share by Type (2017-2028)
    Figure 33. Global Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    Figure 34. Global Interventional Lung Disease Sales Market Share by Application (2017-2028)
    Figure 35. Global Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    Figure 36. North America Interventional Lung Disease Sales Market Share by Type (2017-2028)
    Figure 37. North America Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    Figure 38. North America Interventional Lung Disease Sales Market Share by Application (2017-2028)
    Figure 39. North America Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    Figure 40. North America Interventional Lung Disease Sales Share by Country (2017-2028)
    Figure 41. North America Interventional Lung Disease Revenue Share by Country (2017-2028)
    Figure 42. U.S. Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Interventional Lung Disease Sales Market Share by Type (2017-2028)
    Figure 45. Europe Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Interventional Lung Disease Sales Market Share by Application (2017-2028)
    Figure 47. Europe Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Interventional Lung Disease Sales Share by Country (2017-2028)
    Figure 49. Europe Interventional Lung Disease Revenue Share by Country (2017-2028)
    Figure 50. Germany Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 51. France Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Interventional Lung Disease Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Interventional Lung Disease Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Interventional Lung Disease Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Interventional Lung Disease Revenue Share by Region (2017-2028)
    Figure 61. China Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 64. India Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Interventional Lung Disease Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Interventional Lung Disease Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Interventional Lung Disease Sales Share by Country (2017-2028)
    Figure 76. Latin America Interventional Lung Disease Revenue Share by Country (2017-2028)
    Figure 77. Mexico Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Interventional Lung Disease Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Interventional Lung Disease Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Interventional Lung Disease Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Interventional Lung Disease Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Interventional Lung Disease Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Interventional Lung Disease Revenue Share by Country (2017-2028)
    Figure 86. Turkey Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Interventional Lung Disease Revenue (2017-2028) & (US$ Million)
    Figure 89. Interventional Lung Disease Value Chain
    Figure 90. Interventional Lung Disease Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed